Search clinical trials for: zone-Model Predictive Control algorithm

Respiratory Syncytial Virus Infections

COVID-19 Vaccine Adverse Reaction

Anesthesia

Epilepsy

DiGeorge Anomaly | Complete DiGeorge Anomaly | Complete DiGeorge Syndrome | Complete Atypical DiGeorge Anomaly | Complete Atypical DiGeorge Syndrome

Orthopaedic Fractures

Lymphoma

Lymphoma

Lymphoma

Adult Acute Lymphoblastic Leukemia in Remission

COVID-19 | Hypertension

Burns

Bipolar Depression | Major Depressive Disorder | Schizophrenia and Related Disorders

Bipolar Disorder

Ischemic Stroke | High Blood Pressure

Air Travel

Drug Interactions

Acute Lymphoblastic Leukemia, in Relapse | Therapy-Related Myelodysplastic Syndrome | Acute Leukemia of Ambiguous Lineage | Acute Leukemia of Ambiguous Lineage in Relapse | Myelodysplastic Syndromes, Previously Treated | Acute Lymphoblastic Leukemia With Failed Remission | Myelodysplastic Syndromes, de Novo | Myelodysplastic Syndromes, Secondary | Treatment-Related Acute Myeloid Leukemia | Lymphoblastic Lymphoma, in Relapse

B Acute Lymphoblastic Leukemia

HER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast Cancer

Leukemia

Lymphoma | Leukemia | Cardiac Toxicity

B-cell Adult Acute Lymphoblastic Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia | Untreated Adult Acute Lymphoblastic Leukemia | Blastic Phase Chronic Myelogenous Leukemia

Leukemia | Drug/Agent Toxicity by Tissue/Organ

Lymphoma

Embryonal Rhabdomyosarcoma | Fusion-Negative Alveolar Rhabdomyosarcoma | Spindle Cell/Sclerosing Rhabdomyosarcoma

Recurrent Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Refractory Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Lymphoma | Clonal Cytopenia of Undetermined Significance | High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements

Hypertension | COVID

Alpha-1 Antitrypsin Deficiency | Liver Fibrosis | AATD | AAT Deficiency

Drug-drug Interaction

Breast Cancer | Atrophic Vaginitis

B-cell Childhood Acute Lymphoblastic Leukemia | L1 Childhood Acute Lymphoblastic Leukemia | L2 Childhood Acute Lymphoblastic Leukemia | Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia

Leukemia

Hydatidiform Mole | Choriocarcinoma | FIGO Stage I Gestational Trophoblastic Tumor | FIGO Stage II Gestational Trophoblastic Tumor | FIGO Stage III Gestational Trophoblastic Tumor

B-cell Adult Acute Lymphoblastic Leukemia | Acute Undifferentiated Leukemia | Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia | B-cell Childhood Acute Lymphoblastic Leukemia | L1 Childhood Acute Lymphoblastic Leukemia | L2 Childhood Acute Lymphoblastic Leukemia | T-cell Childhood Acute Lymphoblastic Leukemia | Untreated Adult Acute Lymphoblastic Leukemia | Untreated Childhood Acute Lymphoblastic Leukemia | T-cell Adult Acute Lymphoblastic Leukemia

Breast Cancer Organoids

Leukemia

Lymphoma | Leukemia

Lymphoma

Anesthesia | Opioid Use

Healthy

Stage IV Adult Lymphoblastic Lymphoma | Contiguous Stage II Adult Lymphoblastic Lymphoma | Noncontiguous Stage II Adult Lymphoblastic Lymphoma | Stage I Adult Lymphoblastic Lymphoma | Stage III Adult Lymphoblastic Lymphoma | Untreated Adult Acute Lymphoblastic Leukemia

Leukemia

Sarcoma

Solid Tumor, Adult

Epilepsies, Partial

Drug Interaction

Bipolar Disorder

Recurrent Prostate Cancer | Castration-resistant Prostate Cancer | Biochemically Recurrent Prostate Carcinoma | Recurrent Castration-Sensitive Prostate Carcinoma

Diffuse Large B-Cell Lymphoma | Burkitt Lymphoma | KSHV-associated Multicentric Castleman Disease